Ask AI
ProCE Banner Series

From Evidence to Action: Expert Strategies for Individualizing CD38-Based Quadruplet Therapy in Transplant-Eligible NDMM

Join us online for this interactive symposium to hear from international experts on the latest cutting-edge evidence and guidance needed to provide personalized frontline treatment for patients with multiple myeloma using CD38-based quadruplet regimens.

  AMA
Who Should Attend

This activity is intended for European bone marrow transplant specialists, hematologists, medical oncologists, and other healthcare professionals caring for patients with newly diagnosed multiple myeloma.

All Events

From Evidence to Action: Expert Strategies for Individualizing CD38-Based Quadruplet Therapy in Transplant-Eligible NDMM

Upcoming Events

May

07

2026

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Topics

Multiple myeloma

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ knowledge, confidence, and competence in the management of patients with transplant-eligible newly diagnosed multiple myeloma.

Target Audience
This activity is intended for European bone marrow transplant specialists, hematologists, medical oncologists, and other healthcare professionals caring for patients with newly diagnosed multiple myeloma.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Develop individualized treatments leveraging anti-CD38 antibody–based quadruplet regimens for patients with newly diagnosed transplant-eligible MM based on current data, approvals, clinical data, expert recommendations, and patient/disease factors

  • Assess the clinical utility of MRD for guiding maintenance therapy and other treatment decisions in the induction setting for patients with transplant-eligible MM

  • Plan supportive care approaches to mitigate the risk of treatment-related adverse events in patients with newly diagnosed MM initiating treatment with anti-CD38 antibody–based quadruplet regimens

  • Appraise emerging data for novel methods of anti-CD38 antibody administration and their implications for reducing treatment burden among patients, caregivers, and HCPs

  • Implement strategies supporting equitable access to anti-CD38 antibody–based quadruplet regimens and supportive care in underserved patients with transplant-eligible MM

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

EBAH-CME Accreditation

The program of From Evidence to Action: Expert Strategies for Individualizing CD38-Based Quadruplet Therapy in Transplant-Eligible NDMM has been reviewed and approved for CME accreditation by the European Board for Accreditation in Hematology (EBAH) CME Unit. The EBAH-CME Unit has approved this educational activity for a maximum of 1.0 CME credit. Each physician should only claim credits for time that they actually spent in the educational activity.

All participants may print a European Board for Accreditation in Hematology (EBAH) CME certificate indicating EBAH-CME Credit Points awarded, directly from the system on the CME section of the EBAH website at (www.ebah.org).

How to collect your EBAH-CME credit points:

· Visit our website: ebah.org

· Create a CME account or log in is simple and free of cost

· Please inform your details to the event organizer, so they can add your EBAH-CME credit points

Within the EBAH-CME system, you can:

· Print your EBAH-CME certificates

· Review and manage your personal account

· Search for accredited events based on the European Hematology Curriculum

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Sanofi Genzyme.

Sanofi Genzyme

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191